Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Dr. Michael D. Lesh is a highly accomplished cardiologist, cardiac electrophysiologist, inventor, and serial entrepreneur with extensive experience in academic medicine and the medical device industry. He is recognized for his pioneering work in the treatment of atrial fibrillation and other cardiac arrhythmias. Dr. Lesh served as Professor of Medicine and Chief of Cardiac Electrophysiology at the University of California, San Francisco (UCSF). He has founded multiple successful medical technology companies, including Atrionix (acquired by Johnson & Johnson), Appriva Medical (acquired by Medtronic), and MyPace (now Axon Therapies), where he serves as CEO. His work focuses on developing innovative, less invasive therapies for cardiovascular diseases, significantly impacting patient care worldwide.
Michael D. Lesh, SM MD FACC's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Dr. Lesh is globally recognized for his foundational research and development of catheter-based ablation techniques for atrial fibrillation, which have become a cornerstone of modern arrhythmia management.
Founded and led multiple innovative medical device companies, including Atrionix (focused on AF ablation, acquired by J&J), Appriva Medical (left atrial appendage occlusion, acquired by Medtronic), and currently CEO of Axon Therapies (developing a novel therapy for heart failure).
Served as Professor of Medicine and Chief of the Cardiac Electrophysiology section at the University of California, San Francisco (UCSF), contributing significantly to research, teaching, and clinical excellence.
Holds numerous U.S. and international patents for medical devices and procedures, particularly in the field of cardiac rhythm management and cardiovascular therapies.
Recognized by his peers for his significant contributions to cardiovascular medicine and his commitment to the highest standards of patient care and research.
Massachusetts Institute of Technology - Year 1971
University of California, San Francisco - Year 1977
University of California, San Francisco - Year 1981
University of Pennsylvania School of Medicine - Year 1985
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Quench USA, Inc. offers businesses a wide array of filtered water solutions, including bottleless water coolers, ice machines, sparkling water dispensers, and coffee brewers. They focus on providing sustainable, cost-effective, and convenient hydration and beverage options for workplaces and commercial environments, aiming to eliminate the environmental impact and hassle of traditional bottled water delivery and single-use plastic bottles.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.